News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • In a nationwide study of women with triple-negative breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy drugs brought a sharp increase in the number of patients whose tumors shrank away completely.

Tags: chemotherapy, BreastCancer

  • Combination of cell-killing drug and monoclonal antibody slowed or halted tumor growth in almost half a group of patients whose cancers had become resistant to standard treatments.

Tags: Antibody, BreastCancer

  • Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by Dana-Farber researchers.

Tags: BreastCancer

  • The American Society of Clinical Oncology (ASCO) today issued a new clinical practice guideline on chemotherapy and targeted therapy for women with HER2-negative advanced breast cancer. The guideline provides detailed, evidenced-based information on the efficacy and side effects of various therapies.

Tags: BreastCancer

  • Black and Hispanic women are less likely than white women to receive the radiation therapy routinely prescribed following surgery for early breast cancer, according to a study by Dana-Farber researchers.

Tags: BreastCancer, Disparities

  • Adding a PI3K inhibitor to hormonal therapy for metastatic breast cancer may help overcome resistance to the hormonal therapy and delay disease progression, according to investigators from Dana-Farber Cancer Institute.

Tags: BreastCancer

  • Dana-Farber researchers have demonstrated a molecular strategy that they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.

Tags: BreastCancer, OvarianCancer, GynecologicCancers

  • Results of the study show greater efforts are needed to ensure that all women receive the most effective breast cancer care, regardless of their race or ethnicity.

Tags: BreastCancer, Disparities

  • In one of the largest breast cancer sequencing efforts to date, scientists from Dana-Farber and their colleagues have discovered surprising alterations in genes that were not previously associated with breast cancer.

Tags: BasicResearch, BreastCancer, Genomics

  • The committee will help the CDC develop evidence-based approaches to advance the understanding and awareness of breast cancer among young women.

Tags: BreastCancer

Showing 1-10 of 50 items